Beyond BTK Inhibitors: Next Gen MS Treatments Could Transcend Symptom Management

Retrieved on: 2025-10-06 04:29:04

Tags for this article:

Click the tags to see associated articles and topics

Beyond BTK Inhibitors: Next Gen MS Treatments Could Transcend Symptom Management. View article details on hiswai:

Excerpt

Roche currently has three Phase III trials underway in relapsing MS and primary-progressive MS. BTK inhibitors' ability to cross the blood-brain ...

Article found on: www.biospace.com